MoonLake Immunotherapeutics — 8-K Filings
45 8-K filings on record
This page lists all 8-K filings submitted to the SEC by MoonLake Immunotherapeutics (MLTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. MoonLake Immunotherapeutics has filed 45 8-K documents with the SEC since 2020. To view all SEC filings by MoonLake Immunotherapeutics, see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
EFFECT
NT 10-Q
POS AM
PREM14A
PRER14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-018967 | Feb 23, 2026 | Feb 18, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-002344 | Jan 8, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-25-106723 | Nov 5, 2025 | — |
| 8-K | 8-K | 0001821586-25-000021 | Nov 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-092614 | Sep 29, 2025 | — |
| 8-K | 8-K | 0001821586-25-000016 | Aug 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-052140 | Jun 6, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0001821586-25-000009 | May 12, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-036363 | Apr 29, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-028366 | Apr 3, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001821586-25-000004 | Feb 26, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-24-110169 | Dec 18, 2024 | Dec 12, 2024 |
| 8-K | 8-K | 0001821586-24-000028 | Nov 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-077513 | Sep 11, 2024 | — |
| 8-K | 8-K | 0001821586-24-000024 | Aug 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-051263 | Jun 10, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-050194 | Jun 6, 2024 | Jun 5, 2024 |
| 8-K | 8-K | 0001821586-24-000019 | May 7, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-021233 | Mar 11, 2024 | Mar 10, 2024 |
| 8-K | 8-K | 0001821586-24-000007 | Feb 29, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-016737 | Feb 26, 2024 | — |
| 8-K | 8-K | 0001821586-23-000020 | Nov 14, 2023 | — |
| 8-K | 8-K | 0001628280-23-036888 | Nov 6, 2023 | Nov 5, 2023 |
| 8-K | CURRENT REPORT | 0001013762-23-003933 | Oct 16, 2023 | Oct 15, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-075653 | Sep 11, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-073296 | Sep 1, 2023 | Aug 30, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-065274 | Aug 10, 2023 | — |
| 8-K | 8-K | 0001628280-23-023905 | Jun 29, 2023 | Jun 27, 2023 |
| 8-K | 8-K | 0001628280-23-023381 | Jun 26, 2023 | — |
| 8-K | FORM 8-K | 0001213900-23-047184 | Jun 7, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-041556 | May 19, 2023 | May 15, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-030849 | Apr 19, 2023 | — |
| 8-K | 8-K | 0001821586-23-000004 | Mar 20, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-019254 | Mar 10, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-22-033592 | Jun 17, 2022 | Jun 15, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-031476 | Jun 7, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-019217 | Apr 11, 2022 | Apr 5, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-016984 | Mar 31, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-014894 | Mar 24, 2022 | Mar 21, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-009481 | Feb 25, 2022 | Feb 20, 2022 |
| 8-K | CURRENT REPORT | 0001213900-21-063323 | Dec 3, 2021 | Nov 30, 2021 |
| 8-K | CURRENT REPORT | 0001213900-21-051257 | Oct 4, 2021 | — |
| 8-K | CURRENT REPORT | 0001213900-21-024220 | May 3, 2021 | Apr 27, 2021 |
| 8-K | CURRENT REPORT | 0001213900-20-033731 | Oct 28, 2020 | Oct 22, 2020 |
| 8-K | CURRENT REPORT | 0001213900-20-032858 | Oct 22, 2020 | Oct 19, 2020 |